首页 > 产品目录 > 生命科学
生命科学
显示方式
图片 名称及描述
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(4-pyridinecarboxylate) (ACI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(4-piperidinecarboxylate) (ACI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(8-aminooctanoate) (ACI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[4-(2-fluoroethyl)phenyl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[4-(2,2,3,3,4,4,4-heptafluorobutoxy)phenyl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(2-methyldodecanoate) (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(2,2-dimethyldodecanoate) (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-N-propyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(3,4,5-trimethoxybenzenepropanoate) (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-dodecyl-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-methyl-3-O-methyl-, 2-decanoate (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-N-methyl-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 2-O-decyl-1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-[(undecyloxy)carbonyl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-tetradecanoate (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-dodecanoate (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(11-aminoundecanoate) (ACI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2-O-hexyl-3-O-methyl- (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(α-methyl-4-nitrobenzeneacetate) (9CI)
97%
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[4-(dimethylamino)phenyl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
97%
有竞争力的价格
高效物流
技术支持
货物充足